What Happened?
, -based Impedimed Appointed Eric Mueller as Director of Financial Planning and Analysis
About the Company
Impedimed Ltd. is the world leader in the development and distribution of medical devices employing Bioimpedance Spectroscopy (BIS) technologies for use in the non-invasive clinical assessment and monitoring of fluid status. Impedimed`s primary product range consists of a number of medical devices that aid surgeons, oncologists, therapists and radiation oncologists in the clinical assessment of patients for the potential onset of secondary lymphoedema. Pre-operative clinical assessment in breast cancer survivors, before the onset of symptoms, may prevent the condition from becoming a lifelong management issue and thus improve the quality of life of the cancer survivor. Impedimed had the first medical device with an FDA clearance in the United States to aid health care professionals in the clinical assessment of secondary lymphoedema of the arm in female breast cancer patients.
About the Person
Eric Mueller is Director of Financial Planning and Analysis at Impedimed. Previously, Eric held various senior HR leadership roles in the industry.
Info Source
News
Short Profile